Home Banner 3 Home Banner 4 Home Banner 5 Home Banner 1 Home Banner 2

Features

 

After more than 20 years of clinical research, development and review, Emmaus Medical received FDA approval for Endari™ (L-glutamine oral powder), a breakthrough for patients living with sickle cell disease. Endari is the first treatment in nearly 20 years to reduce the severe complications of sickle cell disease, and the only treatment approved for use in children five years and older.

Continue reading...